Best in Biotech 17 May 2023
Six Norwegian companies leading the country’s biotech scene
Best known for its folklore and tales of the Vikings, Norway’s landscape boasts postcard-like islands and the northern lights. In…
Norway
- Latest Posts
News and Trends 16 Feb 2023
Cytovation melanoma study under way
Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its first-in-class targeted tumor membrane immunotherapy,…
News and Trends 31 Jan 2023
The next breakthrough in cancer treatment?
In our body, we have an innate immune system and an immune system that is developed throughout life. Part of…
News and Trends 22 Dec 2022
Watch: Norway’s Pre Diagnostics looks to early detection of Alzheimer’s
Pre Diagnostics AS is a new Norwegian company developing and commercializing an innovative and effective diagnostic test for Alzheimer’s disease…
ADVERTISEMENT
News and Trends 19 Dec 2022
SoftOx receives chronic wound study report
Norwegian company SoftOx Solutions AS says it has received the final report and analysis of its phase 1 study evaluating…
News and Trends 19 Dec 2022
Nykode Therapeutics and Richter-Helm BioLogics announce partnership
Nykode Therapeutics ASA has entered into a strategic manufacturing partnership with Richter-Helm BioLogics GmbH & Co KG to supply plasmid…
News and Trends 7 Nov 2022
First patient dose completed for bladder cancer diagnostic drug
Asieris Pharmaceuticals says it has completed the first patient dose in its phase III bridging trial for Hexvix, a drug used…
News and Trends 14 Oct 2022
Cytel signs agreement with two Scandinavian medicinal product companies
U.S.-based Cytel Inc. has entered into an agreement to acquire Scandinavian companies SDS Life Sciences AB and SDS MedeQ AB.…
News and Trends 16 Sep 2022
Beyond Biotech podcast 14: Nordic Life Science NLS Days 2022
This week’s podcast is dedicated to Nordic Life Science Days, otherwise known as NLS Days. This year’s version is an…
News and Trends 7 Sep 2022
Lytix Biopharma expanding advanced melanoma study to Europe
Lytix Biopharma, a Norwegian immuno-oncology company, has received regulatory approval from European authorities to start its ATLAS-IT-05 study in three…
ADVERTISEMENT
News and Trends 20 Jun 2022
Investment in Hyperthermics’ process to turn biowaste into energy and proteins
Farvatn Private Equity and Måsøval Eiendom have invested in the Norwegian biotechnology company Hyperthermics AS. Through the investment, Farvatn and…
News and Trends 26 Jan 2022
Norwegian Biotech Put on the Map with €18M Oncology Round
The immuno-oncology startup Cytovation has raised €17.7M (NOK 180M) in one of Norway's biggest Series A rounds in life sciences.…
Interview 9 Sep 2020
Biotech Investment in Norway: An Alternative Approach
Norway has not typically been an attractive region for biotech investors, so when Masha Strømme set up her own investment…
Startup Scout 1 Feb 2019
This Biotech Links the Gut Microbiome to Diseases Using Norwegian Poo
In Norway’s capital city of Oslo, the biotech Bio-Me can rapidly screen for specific gut bacteria, gathering data from thousands…
News and Trends 25 May 2018
Norwegian Pancreatic Cancer Vaccine Drastically Improves Survival
Targovax has obtained positive Phase I/II results showing its pancreatic cancer vaccine improved the survival of 32 patients also receiving…
News and Trends 8 Jan 2018
Bang and the Wart is Gone! Norwegian Peptide Destroys HPV-Infected Cells
Cytovation has raised over €3M to finish off pre-clinical testing of its treatment for warts, and to take it into the…
ADVERTISEMENT
News and Trends 20 Dec 2017
Christmas Has Come Early for Nordic Biotechs as a Norwegian Fund Readies €100M Injection
Hadean Ventures has closed its first fund, which it will begin to invest in life sciences companies around Europe, particularly…
News and Trends 16 Nov 2017
Anti-Parasite Drug May Help to Treat Prostate Cancer, Say Norwegian Scientists
Researchers in Norway have found that a drug used to kill parasites like tapeworms can slow the growth of prostate…
News and Trends 12 Sep 2017
Norwegian Biotech Announces Positive Phase I Results for T cell-Stimulating Vaccine
PCI Biotech's T cell-stimulating vaccine enhances the cellular immune response, supporting it as a candidate for use alongside cancer vaccines.…
Startup Scout 7 Jul 2017
A Norwegian Biotech is Aiming at Permanently Removing HPV Skin Infections
This week we're traveling to Bergen, a beautiful coastal city in Norway surrounded by seven mountains, where a biotech called…
